114 related articles for article (PubMed ID: 11263931)
1. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.
Ayhan A; Tok EC; Bildirici I; Ayhan A
Gynecol Oncol; 2001 Mar; 80(3):355-8. PubMed ID: 11263931
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of the expression of CD44v2 in colorectal cancer.
Haruyama K; Matsumura Y; Moriya Y; Kakizoe T; Ochiai A; Kawaguchi M; Saito T
Anticancer Res; 1999; 19(5C):4421-8. PubMed ID: 10650786
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
9. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
10. Significance of CD44v6 expression in gynecologic malignancies.
Hong SC; Song JY; Lee JK; Lee NW; Kim SH; Yeom BW; Lee KW
J Obstet Gynaecol Res; 2006 Aug; 32(4):379-86. PubMed ID: 16882263
[TBL] [Abstract][Full Text] [Related]
11. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
Ayhan A; Baykal C; Al A; Ayhan A
Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
13. Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.
Matsuo T; Nakamura K; Takamoto N; Kodama J; Hongo A; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
Anticancer Res; 2008; 28(1A):159-64. PubMed ID: 18383840
[TBL] [Abstract][Full Text] [Related]
14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
15. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
18. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes.
Brown AK; Madom L; Moore R; Granai CO; DiSilvestro P
Gynecol Oncol; 2007 Apr; 105(1):55-8. PubMed ID: 17157904
[TBL] [Abstract][Full Text] [Related]
20. CD44-v6 concentrations in carcinoma of the uterine cervix: lack of prognostic significance.
Horn LC; Raptis G; Fischer U; Hentschel B; Köhler U; Richter CE; Martin R
Arch Gynecol Obstet; 2005 Dec; 273(2):104-6. PubMed ID: 16007507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]